Mostrar el registro sencillo del ítem
dc.contributor.author | Miele, Catherine H. | |
dc.contributor.author | Grigsby, Matthew R. | |
dc.contributor.author | Siddharthan, Trishul | |
dc.contributor.author | Gilman, Robert Hugh | |
dc.contributor.author | Miranda, J. Jaime | |
dc.contributor.author | Bernabé Ortiz, Antonio | |
dc.contributor.author | Wise, Robert A. | |
dc.contributor.author | Checkley, William | |
dc.date.accessioned | 2018-11-30T03:10:45Z | |
dc.date.available | 2018-11-30T03:10:45Z | |
dc.date.issued | 2018 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12866/4055 | |
dc.description.abstract | BACKGROUND: Chronic lung disease is a leading contributor to the global disease burden; however, beyond tobacco smoke, we do not fully understand what risk factors contribute to lung function decline in low-income and middle-income countries. METHODS: We collected sociodemographic and clinical data in a randomly selected, age-stratified, sex-stratified and site-stratified population-based sample of 3048 adults aged ≥35 years from four resource-poor settings in Peru. We assessed baseline and annual pre-bronchodilator and post-bronchodilator lung function over 3 years. We used linear mixed-effects models to assess biological, socioeconomic and environmental risk factors associated with accelerated lung function decline. RESULTS: Mean±SD enrolment age was 55.4±12.5 years, 49.2% were male and mean follow-up time was 2.36 (SD 0.61) years. Mean annual pre-bronchodilator FEV1 decline was 30.3 mL/year (95% CI 28.6 to 32.0) and pre-bronchodilator FVC decline was 32.2 mL/year (30.0 to 34.4). Using multivariable linear mixed-effects regression, we found that urban living, high-altitude dwelling and having hypertension accounted for 25.9% (95% CI 15.7% to 36.1%), 21.3% (11.1% to 31.5%) and 15.7% (3.7% to 26.9%) of the overall mean annual decline in pre-bronchodilator FEV1/height2, respectively. Corresponding estimates for pre-bronchodilator FVC/height2 were 42.1% (95% CI% 29.8% to 54.4%), 36.0% (23.7% to 48.2%) and 15.8% (2.6% to 28.9%) of the overall mean annual decline, respectively. CONCLUSION: Urbanisation, living at high altitude and hypertension were associated with accelerated lung function decline in a population with low daily smoking prevalence. | en_US |
dc.language.iso | eng | |
dc.publisher | BMJ Publishing Group | |
dc.relation.ispartofseries | Thorax | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.subject | copd epidemiology | en_US |
dc.subject | not applicable | en_US |
dc.subject | tobacco and the lung | en_US |
dc.title | Environmental exposures and systemic hypertension are risk factors for decline in lung function | en_US |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | https://doi.org/10.1136/thoraxjnl-2017-210477 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.02.07 | |
dc.relation.issn | 1468-3296 |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |